LEARN ABOUT

Pharmacovigilance

Mandate

Department of Pharmacovigilance and Clinical Trials at BoMRA is responsible for the following functions:

Organogram

Mandate

Department of Pharmacovigilance and Clinical Trials at BoMRA is responsible for the following functions:

  • CEO
    Head of Department
    • Main
      Supervisor
      • Mid
        Staff
      • Mid
        Staff
      • Mid
        Staff
    • Main
      Supervisor
      • Mid
        Staff
      • Mid
        Staff
      • Mid
        Staff

To achieve its mandate and objective the Directorate/Department works very closely with different stakeholders including;

To achieve its mandate and objective the Directorate/Department works very closely with different stakeholders including;

Quality Management

Below is a graphical presentation of the stakeholders and how each fits into the medicines/vaccine’s safety surveillance activities.

safety_surveillance_activities
Edit

BoMRA strongly believes in continuous engagement and education of its stakeholders in achieving its mandate of promoting access to and safe use of medicines. Despite travel and meeting restrictions due to the Covid-19 Pandemic, BoMRA conducted 75 training sessions since January 2021 and imparted training to a total of 1200 healthcare professionals across the length and breadth of the country. The feedback from training participants was, that the participants were generally happy about the contents and duration of the training as it provides useful information for them. The attendees requested periodic training to keep on updating their knowledge and skills around medicines/vaccine safety.

Edit

Launch Of Adverse Drug Reaction Monitoring Centres

To build a robust and sustainable national Pharmacovigilance Programme, the Directorate established ADR Monitoring Centres (AMCs) in different hospitals in different geographical regions in the country. The functions of the AMCs are to

To date, BoMRA has launched a total of 10 AMCs in the country.

BoMRA+PV

To build a robust and sustainable national Pharmacovigilance Programme, the Directorate established ADR Monitoring Centres (AMCs) in different hospitals in different geographical regions in the country. The functions of the AMCs are to

To date, BoMRA has launched a total of 10 AMCs in the country.

BoMRA PV
Edit

Adverse events following immunisation (AEFI) which is also vaccine safety surveillance was handed over to BoMRA from the Expanded Programme of Immunisation (EPI) in March 2021. This was followed by a series of engagements with DHMTs and the revitalisation of the National AEFI Committee. This is a committee of experts within the medical field who offers independent scientific advice to BoMRA and EPI on vaccine safety issues.

 

BoMRA has managed to receive a total of  1451 AEFI reports and is one of the top three most reporting countries amongst the 20 countries in southern and eastern Africa. The committee is made up of 11 members representing different expertise, and speciality groups. The committee is made up of the following professionals:

National_AEFI_Committee

Advocacy And Training

BoMRA strongly believes in continuous engagement and education of its stakeholders in achieving its mandate of promoting access to and safe use of medicines. Despite travel and meeting restrictions due to the Covid-19 Pandemic, BoMRA conducted 75 training sessions since January 2021 and imparted training to a total of 1200 healthcare professionals across the length and breadth of the country. The feedback from training participants was, the participants were generally happy about the contents and duration of training as it provides useful information for them. The attendees requested periodic training to keep on updating their knowledge and skills in the area of medicines/vaccines safety.

Launch Of Adverse Drug Reaction Monitoring Centres

To build a robust and sustainable national Pharmacovigilance Programme, the Directorate established ADR Monitoring Centres (AMCs) in different hospitals in different geographical regions in the country. The functions of the AMCs are to

Launch Of Adverse Drug Reaction Monitoring Centres

To build a robust and sustainable national Pharmacovigilance Programme, the Directorate established ADR Monitoring Centres (AMCs) in different hospitals in different geographical regions in the country. The functions of the AMCs are to

To date, BoMRA has launched a total of 10 AMCs in the country.

Organogram

Introducing Med Safety App

Working together to improve pharmacovigilance through new technology.

Available for download for both Android and IOS

BoMRa-Med-App-glow